Executive readout · one minute
Call research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
SMMT
$17.55
+3.24%
SMMT
· Summit Therapeutics Inc.
$17.55
+0.55 (+3.24%)
At close · Sep 11
Going-concern doubt
— flagged Jul 23, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Jul 23, 2026
Market Cap
$14.00B
Shares
797.75M
All earnings calls
Earnings call · FY2026 Q1
Summit Therapeutics Inc. (SMMT) Q1 2026 Earnings Call
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Apr 30, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Apr 30, 2026 · complete as-filed document